Dean Greer Glazer Elected to Nursing's National Leadership Board
Greer Glazer, PhD, dean of the University of Cincinnati College of Nursing, has been elected to the board of the American Association of Colleges of Nursing (AACN) as a board member at large.
The AACN is a national voice for baccalaureate and graduate programs in nursing and represents more than 700 member schools of nursing at public and private institutions nationwide. Glazer was chosen for this top leadership position by member deans and directors from the nations schools of nursing with baccalaureate and higher degree programs.
The AACN sets quality standards for bachelors and graduate degree nursing education, assists deans and directors to implement those standards, influences the nursing profession to improve health care and promotes public support of baccalaureate and graduate nursing education, research and practice.
Glazers career includes serving for seven years as dean of the College of Nursing and Health Sciences at the University of Massachusetts-Boston, as a trustee of the Health Collaborative serving the Greater Cincinnati area, as a leader in the Massachusetts Association of Colleges of Nursing and as a Robert Wood Johnson Foundation Nurse Executive Fellow. Her service to AACN includes chair of the Executive Development Series Program Committee, member of the Government Affairs Committee and mentor with the New Dean Mentoring Program.
Those elected to the AACN Board and Nominating Committee will begin their terms of service following the business meeting at AACNs Spring Annual Meeting on Monday, March 18, 2013.
For more information, visit www.aacn.nche.edu
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.